Lilly (Eli) Income Statement
LLY / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Lilly (Eli) reported $65.2B in revenue and $20.6B in net income for FY2025. Revenue has grown at a 8.1% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.2B | $45.0B | $28.3B | $24.5B | $22.3B | $21.5B | $22.3B | $21.5B | $20.0B | $21.2B | $20.0B | $19.6B | $23.1B | $23.1B | $21.8B |
| Cost of Revenue | $11.1B | $8.4B | $7.3B | $5.5B | $4.7B | $4.7B | $4.7B | $4.7B | $5.0B | $5.7B | $5.0B | $4.9B | $4.9B | $4.4B | $4.2B |
| SG&A Expense | $11.1B | $8.6B | $6.4B | $6.1B | $6.2B | $6.0B | $6.2B | $6.0B | $6.5B | $6.5B | $6.5B | $6.6B | $7.1B | $7.1B | $6.9B |
| R&D Expense | $13.3B | $11.0B | $6.9B | $6.0B | $5.6B | $5.1B | $5.6B | $5.1B | $4.8B | $5.3B | $4.8B | $4.7B | $5.5B | $4.9B | $4.3B |
| Interest Expense | - | - | $339.8M | $359.6M | $400.6M | $242.5M | $400.6M | $242.5M | $161.2M | $185.2M | $161.2M | $148.8M | $160.1M | $185.5M | $261.3M |
| Income Tax | $5.1B | $2.1B | $573.8M | $1.0B | $628.0M | $529.5M | $628.0M | $529.5M | $381.6M | $636.4M | $381.6M | $609.8M | $1.2B | $1.5B | $1.0B |
| Net Income | $20.6B | $10.6B | $5.6B | $6.2B | $8.3B | $3.2B | $8.3B | $3.2B | $2.4B | $2.7B | $2.4B | $2.4B | $4.7B | $5.1B | $4.3B |
| EPS (Basic) | $5.82 | $6.93 | $6.15 | $6.82 | $8.93 | $3.14 | -$0.19 | $2.59 | $2.27 | $2.23 | $4.33 | $3.67 | $3.90 | $4.58 | $3.94 |
| EPS (Diluted) | $5.80 | $6.90 | $6.12 | $6.79 | $8.89 | $3.13 | -$0.19 | $2.58 | $2.26 | $2.23 | $4.32 | $3.66 | $3.90 | $4.58 | $3.94 |
| Shares Outstanding | 903.3M | 904.6M | 911.7M | 912.5M | 935.7M | 1.0B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | - | 1.1B |
| Profit Margin | 31.7% | 23.5% | 19.7% | 25.2% | 37.3% | 15.0% | 37.3% | 15.0% | 12.1% | 12.9% | 12.1% | 12.2% | 20.3% | 22.0% | 19.8% |